TP53 and cancer: Our unbiased assessment of 800 common cancer-associated p53 mutants previously established Y220C as a non-TS mutant [22, 31], emphasizing that even upon refolding through low-temperature treatment, p53-Y220C cannot be efficaciously restored in function.